Observational studyRevista da Associacao Medica Brasileira (1992)2026
Evaluation of multi-inflammatory ındexes in persons living with human immunodeficiency virus: a multicenter study.
Observational study in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of the study was to evaluate inflammatory markers after 1 year of antiretroviral therapies use in persons living with human immunodeficiency virus.
methodsThis is a retrospective, observational, and multicenter study. The study included adult, comorbid disease-free patients who received antiretroviral therapies with a diagnosis of human immunodeficiency virus infection. Multi-inflammatory index, multi-inflammatory index obtained by various formulations of complete blood count, C-reactive protein, neutrophil count, lymphocyte count, and platelet count, systemic immune-inflammatory index, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, C-reactive protein/lymphocyte ratio, cluster of differentiation 4 (CD4) T lymphocyte percentage, and CD4/CD8 ratio data were compared with pretreatment data.
resultsA total of 391 persons living with human immunodeficiency virus, including 241 (61.6%) women, were included in the study. When pretreatment human immunodeficiency virus ribonucleic acid, neutrophil count, lymphocyte count, platelet count, C-reactive protein level, CD4 percentage, CD8 percentage, CD4/CD8 ratio, multi-inflammatory index-1, multi-inflammatory index-2, and systemic immune-inflammatory index data were compared with the 48th week of treatment, a statistically significant difference was found except for neutrophils (p<0.05). When the 48th week post-treatment data were evaluated, human immunodeficiency virus ribonucleic acid, C-reactive protein, multi-inflammatory index-1, multi-inflammatory index-2, and systemic immune-inflammatory index values decreased; lymphocyte, platelet, CD4, CD8, and CD4/CD8 ratio values increased. Among the pretreatment markers, systemic immune-inflammatory index, platelet/lymphocyte ratio, and neutrophil/lymphocyte ratio predicted CD4/CD8 ratio ≤1 or >1 at the end of 48 weeks at the highest rate (60.7, 60, and 59.6%, respectively).
conclusionMulti-inflammatory markers were found to regress after antiretroviral therapies use in persons living with human immunodeficiency virus. In the long term, these patients should be monitored for the effects of chronic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.